Anticancer agents against malaria: time to revisit?
Authors:
Open Access
- 6 January 2010
- journal article
- review article
- Published by Elsevier in Trends in Parasitology
- Vol. 26 (3) , 125-129
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- In Vitro Activity of Antifolate and Polymorphism in Dihydrofolate Reductase ofPlasmodium falciparumIsolates from the Kenyan Coast: Emergence of Parasites with Ile-164-Leu MutationAntimicrobial Agents and Chemotherapy, 2009
- Artemisinin Resistance inPlasmodium falciparumMalariaNew England Journal of Medicine, 2009
- Azithromycin-chloroquine and the intermittent preventive treatment of malaria in pregnancyMalaria Journal, 2008
- Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studiesArthritis Research & Therapy, 2008
- Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from GabonMalaria Journal, 2008
- Effect of folate derivatives on the activity of antifolate drugs used against malaria and cancerParasitology Research, 2008
- Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literatureRheumatology International, 2007
- TrimetrexateDrugs, 1995
- Clinical Pharmacokinetics and Pharmacology of TrimetrexateClinical Pharmacokinetics, 1994
- Treatment of Severe Chloroquine PoisoningNew England Journal of Medicine, 1988